The outcomes of allogeneic stem cell transplantation in AML patients with monosomal karyotypes

被引：0
|
作者：
Sohn, S. K. [1 ]
Moon, J. H. [1 ]
Lee, Y. J. [1 ]
Lee, S. J. [1 ]
Do, Y. R. [2 ]
Kim, Y. K. [1 ]
Suh, J. S. [1 ]
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Keimyung Univ, Dongsan Hosp, Taegu, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S99 / S100
页数：2
相关论文
共 50 条
  • [41] Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Backhaus, Donata
    Jentzsch, Madlen
    Bischof, Lara
    Brauer, Dominic
    Wilhelm, Christina
    Schulz, Julia
    Franke, Georg-Nikolaus
    Poenisch, Wolfram
    Vucinic, Vladan
    Platzbecker, Uwe
    Schwind, Sebastian
    CANCERS, 2021, 13 (22)
  • [42] Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
    Short, Nicholas J.
    Ong, Faustine
    Ravandi, Farhad
    Nogueras-Gonzalez, Graciela
    Kadia, Tapan M.
    Daver, Naval
    DiNardo, Courtney D.
    Konopleva, Marina
    Borthakur, Gautam
    Oran, Betul
    Al-Atrash, Gheath
    Mehta, Rohtesh
    Jabbour, Elias J.
    Yilmaz, Musa
    Issa, Ghayas C.
    Maiti, Abhishek
    Champlin, Richard E.
    Kantarjian, Hagop
    Shpall, Elizabeth J.
    Popat, Uday
    BLOOD ADVANCES, 2023, 7 (14) : 3573 - 3581
  • [43] Impact of prior solid tumor on outcomes of allogeneic hematopoietic stem cell transplantation for AML or MDS.
    Albittar, Aya
    Portuguese, Andrew Jay
    Gooley, Ted
    Deeg, H. Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [44] The Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in AML patients Registered in the Japan Adult Leukemia Study Group (JALSG) Study
    Ishiyama, K.
    Ohtake, S.
    Miyamura, K.
    Kiyoi, H.
    Miyazaki, Y.
    Miyawaki, S.
    Ohno, R.
    Kobayashi, Y.
    Naoe, T.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S284 - S284
  • [45] Allogeneic stem cell transplantation and minimal residual disease in patients with AML in first complete remission
    Versluis, Jurjen
    Cornelissen, Jan J.
    HEMASPHERE, 2018, 2 : 162 - 164
  • [46] HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
    Roerden, Malte
    Nelde, Annika
    Heitmann, Jonas S.
    Klein, Reinhild
    Rammensee, Hans-Georg
    Bethge, Wolfgang A.
    Walz, Juliane S.
    CANCERS, 2020, 12 (07) : 1 - 10
  • [47] Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation
    Nachbaur, D.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 104 - 107
  • [48] Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation
    David Nachbaur
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 104 - 107
  • [49] Paediatric allogeneic and autologous stem cell transplantation in AML: Istanbul experience
    Anak, S
    Bilgen, H
    Can, E
    Ozgenc, S
    Gedikoglu, G
    BONE MARROW TRANSPLANTATION, 2002, 30 : S58 - S58
  • [50] Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS
    Kennedy, GA
    Butler, J
    Durrant, S
    Hill, GR
    Western, R
    Morton, J
    BLOOD, 2005, 106 (11) : 438B - 439B
12345